PROLOR Biotech shares gained 3 percent on more than double the average daily volume Wednesday. The company announced that its longer-acting version of human growth hormone has received orphan drug designation in Europe.
Going forward ... (see research report)
Copyright ® 2016. The Bedford Report. All Rights Reserved.